- KYMR +0.47%
Search results
- 34.40Add to watchlist+0.16 (+0.47%)As of Fri. May 24, 2024 2:35 PM EDT · Nasdaq Real Time Price (USD) · Market open
- Open34.38High36.00Low33.95
- Mkt Cap2.11BP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close34.2452 Wk. Low9.6052 Wk. High45.31
Top storiesKymera Therapeutics, Inc. (NASDAQ:KYMR) Just Released Its First-Quarter Earnings: Here's What Analysts ThinkYahoo Finance · 3 weeks agoZacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and LigandYahoo Finance · 2 weeks agoRelated stocks
May 2, 2024 · Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Stock Information. KYMR. May 15, 2024. $35.47. + 0.38/+1.08% Data Provided by Refinitiv.
- www.marketwatch.com
- …
- Quotes
- Stocks
- United States
May 2, 2024 · KYMR | Complete Kymera Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
3 days ago · Kymera Therapeutics Inc. KYMR:US. Nasdaq GM (USD) · Market closed. 36.01. +1.06 +3.03% As of 8:00 PM EDT 05/20/24. Prev. close. 34.95 USD. 36.01 USD. 3:58 PM. 9:30a 10:30a 11:30a 12:30p 1:30p...
Discover real-time Kymera Therapeutics, Inc. Common Stock (KYMR) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
2 days ago · with Phase 1 data in the first half of 2025. WATERTOWN, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new ...
View the latest Kymera Therapeutics Inc. (KYMR) stock price, news, historical charts, analyst ratings and financial information from WSJ.
A high-level overview of Kymera Therapeutics, Inc. (KYMR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.